On January 14, 2025, the U.S. Securities and Exchange Commission (SEC) charged Presto Automation Inc. (Presto) with violations of the Securities Act of 1933 and the Securities Exchange Act of 1934 for misleading artificial...more
2/4/2025
/ Artificial Intelligence ,
Compliance ,
Disclosure Requirements ,
Enforcement Actions ,
Fraud ,
Machine Learning ,
Publicly-Traded Companies ,
Risk Management ,
Securities Act of 1933 ,
Securities and Exchange Commission (SEC) ,
Securities Exchange Act of 1934 ,
Securities Regulation ,
Securities Violations ,
Technology Sector
The U.S. Senate and the U.S. House of Representatives are both considering legislation that could have a serious impact on the ability of U.S. biotechnology, drug, and medical device companies to do business with...more
3/19/2024
/ Artificial Intelligence ,
Biosimilars ,
Biotechnology ,
China ,
Department of Homeland Security (DHS) ,
Life Sciences ,
Medical Devices ,
National Security ,
OMB ,
Pharmaceutical Industry ,
Popular ,
Risk Assessment